Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma

World Journal of Surgery

Volumn 37, Issue 6, 2013, Pages 1371-1378

  Kim, Jong Man ^a   Hyuck, Choon ^a   Kwon, David ^a   Joh, Jae Won ^a   Lee, Joon Hyeok ^a   Paik, Seung Woon ^a   Park, Cheol Keun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; PROTEIN PRECURSOR; PROTHROMBIN; TUMOR MARKER;

ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84877746461     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-1966-0     Document Type: Article

References (32)

1. Sherman M (2011) Hepatocellular carcinoma: screening and staging. Clin Liver Dis 15(323-334):7-10
2. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236
3. El-Serag HB, Marrero JA, Rudolph L et al (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134:1752-1763
4. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417-422
5. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
6. Takayama T, Makuuchi M, Kojiro M et al (2008) Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol 15:972-978
7. Santi V, Trevisani F, Gramenzi A et al (2010) Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol 53:291-297
8. Yamashita YI, Tsuijita E, Takeishi K et al (2011) Predictors for microinvasion of small hepatocellular carcinoma ≤2 cm. Ann Surg Oncol 19:2027-2034
9. Nakashima Y, Nakashima O, Tanaka M et al (2003) Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26:142-147
10. Minagawa M, Ikai I, Matsuyama Y et al (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909-922
11. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462-503
12. Nathan H, Schulick RD, Choti MA et al (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249:799-805
13. Pawlik TM, Delman KA, Vauthey JN et al (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11:1086-1092
14. Jonas S, Bechstein WO, Steinmuller T et al (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080-1086
15. Taketomi A, Sanefuji K, Soejima Y et al (2009) Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 87:531-537
16. Fujiki M, Takada Y, Ogura Y et al (2009) Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 9:2362-2371
17. Eguchi S, Takatsuki M, Hidaka M et al (2010) Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 34:1034-1038. doi: 10.1007/s00268-010-0424-5
18. Koike Y, Shiratori Y, Sato S et al (2001) Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91:561-569
19. Shirabe K, Itoh S, Yoshizumi T et al (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma - with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95:235-240
20. Bae HM, Lee JH, Yoon JH et al (2011) Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation. BMC Cancer 11:435
21. Tarao K, Rino Y, Takemiya S et al (2000) Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology 43:20-26
22. Moriyama M, Matsumura H, Aoki H et al (2005) Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy. Liver Int 25:85-90
23. Taketomi A, Takenaka K, Matsumata T et al (1997) Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma before and after hepatic resection. Hepatogastroenterology 44:477-483
24. Chen CH, Hu FC, Huang GT et al (2009) Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - analysis of 2010 Taiwanese patients. Eur J Cancer 45:1630-1639
25. Tong MJ, Chavalitdhamrong D, Lu DS et al (2010) Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J Clin Gastroenterol 44:e63-e70
26. Yu MC, Chan KM, Lee CF et al (2011) Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg 15:1440-1449
27. Gouw AS, Balabaud C, Kusano H et al (2011) Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 17(Suppl 2):S72-S80
28. Sumie S, Kuromatsu R, Okuda K et al (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15:1375-1382
29. Tamano M, Sugaya H, Oguma M et al (2002) Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma. Hepatol Res 22:261-269
30. Fujikawa T, Shiraha H, Ueda N et al (2007) Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem 282:8741-8748
31. Ueno S, Kubo F, Sakoda M et al (2008) Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg 15:493-500
32. Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36-43